美诺华：关于全资子公司获得非布司他片药品注册证书的公告

Core Viewpoint - Menova announced that its wholly-owned subsidiary, Ningbo Menova Tiankang Pharmaceutical Co., Ltd., has received the drug registration certificate for Febuxostat tablets from the National Medical Products Administration [2] Company Summary - Menova's subsidiary has successfully obtained regulatory approval for Febuxostat tablets, indicating a significant milestone in its product development and market entry strategy [2]